| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | Chief Commercial Officer | Common Stock | 72,029 | $3,334,885 | $46.30 | 21 Jan 2026 | Direct |
| SOLENO THERAPEUTICS INC | Chief Commercial Officer | Employee stock option (right to buy) | 32,800 | 21 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 21 Jan 2026 | 2 | $0 | 4 | Chief Commercial Officer | 23 Jan 2026, 18:06 |
| SLNO | SOLENO THERAPEUTICS INC | 15 Dec 2025 | 1 | -$96,004 | 4 | Chief Commercial Officer | 17 Dec 2025, 16:38 |
| SLNO | SOLENO THERAPEUTICS INC | 27 Mar 2025 | 11 | -$1,330,873 | 4 | Chief Commercial Officer | 31 Mar 2025, 19:21 |
| SLNO | SOLENO THERAPEUTICS INC | 21 Jan 2025 | 2 | $0 | 4 | Chief Commercial Officer | 23 Jan 2025, 16:28 |
| SLNO | SOLENO THERAPEUTICS INC | 17 Jul 2024 | 1 | $0 | 4 | Chief Commercial Officer | 19 Jul 2024, 09:04 |
| SLNO | SOLENO THERAPEUTICS INC | 22 Apr 2024 | 0 | $0 | 3 | Chief Commercial Officer | 30 Apr 2024, 17:54 |